Quantum needs a signed deal...…".We believe the POCT market is poised for significant growth and the need for rapid, low-cost, highly sensitive, and quantitative point of care tests can best be meet with quantum dot enabled technologies. We intend to continue the expansion of our biotech staff and capabilities, provided we are able to generate sufficient cash flows from operations or through additional financing.This technology is intended to part of our immediate commercialization focus." Get the proxy approved! first! $5+
(0)
(0)
Quantum Materials Corp. (QTMM) Stock Research Links